Pulmonary vascular disease & thromboembolism

Periprocedural Complications With Balloon Pulmonary Angioplasty: Analysis of Global Studies

JACC Cardiovasc IntervPublished Systematic review and pooled cohort analysis

Authors' conclusion

Procedure-related complications with BPA, including hemoptysis/vascular injury, lung injury/reperfusion edema, mechanical ventilation, and death, were less common in the second period (2018-2022), compared with first period (2013-2017), likely from refinement in patient and lesion selection and procedural technique over time.

Study context

Population
Patients with inoperable, medically refractory chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty (BPA)26 articles
Participants
1,714 patients
Comparison
BPA complications, 2018-2022 vs 2013-2017
Outcome
Procedure-related complications
Follow-up
Average 7.3 months

Pooled result

As reported in the abstract

GroupHemoptysis/vascular injuryLung injury/reperfusion edemaInvasive mechanical ventilationMortality
2013-201714.1% (474/3,351)11.3% (377/3,351)0.7% (23/3,195)2.0% (13/636)
2018-20227.7% (233/3,029)1.4% (57/3,943)0.1% (4/3,062)0.8% (8/1,071)

Hemoptysis/vascular injury

2013-201714.1% (474/3,351)
2018-20227.7% (233/3,029)

Lung injury/reperfusion edema

2013-201711.3% (377/3,351)
2018-20221.4% (57/3,943)

Invasive mechanical ventilation

2013-20170.7% (23/3,195)
2018-20220.1% (4/3,062)

Mortality

2013-20172.0% (13/636)
2018-20220.8% (8/1,071)
  • 2018-2022 vs 2013-2017: P < 0.01 — hemoptysis/vascular injury
  • 2018-2022 vs 2013-2017: P < 0.01 — lung injury/reperfusion edema
  • 2018-2022 vs 2013-2017: P < 0.01 — invasive mechanical ventilation
  • 2018-2022 vs 2013-2017: P < 0.01 — mortality

Original publication

Periprocedural Complications With Balloon Pulmonary Angioplasty: Analysis of Global Studies. JACC Cardiovasc Interv. Published 22 March 2023. doi:10.1016/j.jcin.2023.01.361

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.